ImageneBio Inc
IMA
Rank in Stocks
#23171
ImageneBio Inc (IMA) is a biotechnology company with therapies currently... ImageneBio Inc (IMA) is a biotechnology company with therapies currently undergoing human trials. The firm concentrates on creating innovative medical treatments for a variety of immune-related and inflammatory diseases. A key component of their pipeline is IMG-007, a non-depleting anti-OX40 monoclonal antibody, which is now in Phase 2b clinical studies targeting atopic dermatitis.
Share Price
$3.97
Last synced: 2026-11-09
Market Cap
$45.07M
Change (1 day)
-3.29%
Change (1 year)
-53.89%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade ImageneBio Inc (IMA)
Category
Healthcare
Operating Margin for ImageneBio Inc (IMA)
Operating Margin as of November 2026 TTM: 0.00%
According to ImageneBio Inc's latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of -6,056.38%.
Operating Margin history for ImageneBio Inc from 2018 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | -100.00% |
| 2025 | -6,056.38% | 472.90% |
| 2024 | -1,057.14% | 28.40% |
| 2023 | -823.33% | 81.35% |
| 2022 | -453.99% | 312.04% |
| 2021 | -110.18% | -77.25% |
| 2020 | -484.22% | 260.12% |
| 2019 | -134.46% | -96.74% |
| 2018 | -4,130.71% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about ImageneBio Inc's operating margin
What was ImageneBio Inc's operating margin in 2025?
In 2025, ImageneBio Inc's operating margin was -6,056.38%, compared with -1,057.14% in 2024.
How has ImageneBio Inc's operating margin changed since 2020?
From 2020 to 2025, ImageneBio Inc's operating margin was highest in 2021 (-110.18%) and lowest in 2025 (-6,056.38%).
How does ImageneBio Inc's operating margin compare with similar companies?
ImageneBio Inc's operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.